Thermo Fisher Scientific Inc
NYSE:TMO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
485.92
623.8136
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
Net Income (Common)
Thermo Fisher Scientific Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$3.9B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Net Income (Common)
$499.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$795.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
42%
|
CAGR 10-Years
15%
|
|
Thermo Fisher Scientific Inc
Glance View
Thermo Fisher Scientific Inc. has positioned itself as a leading provider of scientific instruments, reagents, and consumables, playing a pivotal role in the life sciences, healthcare, and laboratory services sectors. Founded in 2006 from the merger of Thermo Electron and Fisher Scientific, the company's mission is to enable customers to make the world healthier, cleaner, and safer. With a diverse portfolio that includes everything from high-tech analytical equipment to diagnostic tests and laboratory management services, Thermo Fisher supports research and development in biotechnology, pharmaceuticals, and environmental applications. The company’s deep commitment to innovation is reflected in its substantial investment in R&D, which ensures that it remains at the cutting edge of scientific technology. For investors, Thermo Fisher represents a robust opportunity in a dynamic and growing market. With its extensive global reach, the company generated over $40 billion in revenue in its last fiscal year, benefiting from strong demand driven by trends in personalized medicine, genomics, and biotechnology advancements. A consistent track record of acquiring complementary companies has bolstered its product offerings and expanded its market presence, providing a competitive edge. As the world increasingly turns to science for solutions in health crises and environmental challenges, Thermo Fisher's value proposition remains strong, making it a compelling choice for investors seeking exposure to the evolving healthcare and life sciences landscape.
See Also
What is Thermo Fisher Scientific Inc's Net Income (Common)?
Net Income (Common)
6.1B
USD
Based on the financial report for Sep 28, 2024, Thermo Fisher Scientific Inc's Net Income (Common) amounts to 6.1B USD.
What is Thermo Fisher Scientific Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
14%
Over the last year, the Net Income (Common) growth was 3%. The average annual Net Income (Common) growth rates for Thermo Fisher Scientific Inc have been -11% over the past three years , 11% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
